177 related articles for article (PubMed ID: 8653325)
1. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
Shiina H; Igawa M; Ishibe T
Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
[TBL] [Abstract][Full Text] [Related]
2. Clinical study on estramustine binding protein (EMBP) in human prostate.
Shiina H; Igawa M; Ishibe T
Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
[TBL] [Abstract][Full Text] [Related]
3. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
Shiina H; Urakami S; Shirakawa H; Igawa M; Ishibe T; Usui T
Eur Urol; 1996; 29(1):106-10. PubMed ID: 8821700
[TBL] [Abstract][Full Text] [Related]
4. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
Shiina H; Sumi H; Ishibe T; Usui T
Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia.
de la Torre M; Eklöv S; Häggman M; Björk P; Busch C; Nilsson S
Prostate; 1994 Sep; 25(3):125-31. PubMed ID: 7520576
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH
Prostate; 1989; 14(1):27-43. PubMed ID: 2648345
[TBL] [Abstract][Full Text] [Related]
8. Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancer.
Nordgren H; Nilsson S; Eklöv S; Stattin P; Naining W; Heiden T; Bergkvist L; Karlberg L; Lundholm C; Harvig B
Acta Oncol; 1991; 30(2):211-4. PubMed ID: 2029408
[TBL] [Abstract][Full Text] [Related]
9. Relationship of thyroid to estramustine binding protein (EMBP) concentration in rat prostate.
Shiina H; Sumi H; Ishibe T; Usui T
Andrologia; 1991; 23(2):145-9. PubMed ID: 1952120
[TBL] [Abstract][Full Text] [Related]
10. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA.
Shiina H; Ishibe T; Usui T
Biochem Biophys Res Commun; 1989 Dec; 165(3):947-55. PubMed ID: 2482024
[TBL] [Abstract][Full Text] [Related]
11. Estramustine binding protein in human benign prostatic hypertrophy.
Shiina H; Mizutani M; Ishibe T
Andrologia; 1990; 22(4):309-12. PubMed ID: 1702270
[TBL] [Abstract][Full Text] [Related]
12. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
Björk P; Isaacs JT; Hartley-Asp B
Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
[TBL] [Abstract][Full Text] [Related]
13. [Endogenous androgen levels of human prostatic tissues].
Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive protein to rat estramustine binding protein in human seminal plasma: its relationship to prostatic acid phosphatase and zinc.
Shiina H; Ishibe T; Usui T
Andrologia; 1991; 23(2):177-9. PubMed ID: 1952125
[TBL] [Abstract][Full Text] [Related]
15. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate.
Bichler KH; Flüchter SH; Nelde HJ; Björk P; Müntzing J
Prostate; 1989; 14(1):13-25. PubMed ID: 2467273
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
18. Purification of estramustine-binding protein and production of monoclonal antibodies to its different components.
Björk P; Donn F; Glad C; Sundblad G; Vestberg M; Kalland T
Prostate; 1995 Aug; 27(2):70-83. PubMed ID: 7638085
[TBL] [Abstract][Full Text] [Related]
19. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
20. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
Björk PA; Flüchter SH; Nelde HJ
Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]